TBPH
Theravance Biopharma Inc
NASDAQ: TBPH · HEALTHCARE · BIOTECHNOLOGY
$16.52
-2.88% today
Updated 2026-05-11
Market cap
$876.78M
P/E ratio
7.63
P/S ratio
7.99x
EPS (TTM)
$2.23
Dividend yield
—
52W range
$8 – $21
Volume
0.6M
Theravance Biopharma Inc (TBPH) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-36.4%
Last 4 quarters
Revenue YoY growth
+144.7%
Most recent quarter
EPS YoY growth
+217.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+25.4%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-04 | $0.06 | -94.1% | $13.96 | $13.58 | -2.7% |
| 2025-11-10 | $0.07 | +153.8% | $14.75 | $18.50 | +25.4% |
| 2025-08-04 | $-0.08 | -112.5% | $10.90 | $11.09 | +1.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $1.00 | $0.06 | -94.1% | $45.89M | +144.7% |
| 2025-09-30 | $-0.13 | $0.07 | +153.8% | $19.99M | +18.5% |
| 2025-06-30 | $0.67 | $-0.08 | -112.5% | $26.20M | +83.7% |
| 2025-03-31 | $-0.09 | $-0.17 | -92.7% | $15.39M | +6.1% |
| 2024-12-31 | $-0.08 | $-0.05 | +39.9% | $18.75M | +6.8% |
| 2024-09-30 | $-0.23 | $-0.06 | +74.3% | $16.87M | +7.5% |
| 2024-06-30 | $-0.21 | $-0.28 | -33.3% | $14.26M | +3.7% |
| 2024-03-31 | $-0.25 | $-0.24 | +4.0% | $14.50M | — |
| 2023-12-31 | $-0.15 | $-0.17 | -13.3% | $17.57M | — |
| 2023-09-30 | $-0.21 | $-0.17 | +19.0% | $15.69M | — |
| 2023-06-30 | $-0.21 | $-0.28 | -33.3% | $13.75M | — |
Frequently asked questions
Has Theravance Biopharma Inc beaten earnings estimates?
Theravance Biopharma Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -36.4% over the last 4 quarters.
How does TBPH stock react to earnings?
TBPH stock has moved an average of +8.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Theravance Biopharma Inc's revenue growth rate?
Theravance Biopharma Inc reported year-over-year revenue growth of +144.7% in its most recent quarter, with EPS growing +217.8% year-over-year.